Purpose: Osteosarcoma is the most common primary bone tumor. Polypeptide N-acetylgalactosaminyltransferase 14 (GALNT14), a member of the N-acetylgalactosaminyltransferase family, has been considered to be associated with various cancers. However, its role in osteosarcoma remains unknown. Here, we aimed to explore the expression and potential mechanism of GALNT14 in osteosarcoma through bioinformatics analysis and in vitro experiments.
Methods: We investigated GALNT14 expression in osteosarcoma using GEO, the TIMER database, and clinical samples. Protein-protein interaction (PPI) network analysis on GALNT14 was performed by STRING. TARGET was used to identify differentially expressed genes (DEGs) between high and low GALNT14 expression. The correlation between GALNT14 and cuproptosis-related genes in osteosarcoma was analyzed by R language. The prognostic significance of GALNT14 was examined by Kaplan-Meier survival analysis. Additionally, we inhibited GALNT14 function in an osteosarcoma cell line by transfecting siRNA and subsequently explored the effect on drug sensitivity by CCK-8, clonogenic assay, and flow cytometry.
Results: GALNT14 was significantly elevated in osteosarcoma tissue, osteosarcoma cell lines, and metastatic osteosarcoma. PPI analysis revealed that GALNT14 was associated with MUC7, MUC13, MUC5AC, C1GALT1, MUC15, MUC16, MUC1, MUC4, MUC21, and MUC17. In the high GALNT14 expression group, we discovered 81 upregulated DEGs and 73 downregulated DEGs. Functional enrichment analysis of DEGs showed significant enrichment in the Wnt, TGF-, Hippo, PI3K signaling pathways and cell adhesion molecules. Expression of cuproptosis-related genes was closely related in osteosarcoma, and GALNT14 expression was significantly positively correlated with FDX1, a key regulator of cuproptosis. Kaplan-Meier survival showed that GALNT14 was linked to poor overall survival and disease-free survival in osteosarcoma. experiments suggested that GALNT14 was associated with chemotherapy resistance in osteosarcoma.
Conclusion: We identified a GALNT family gene, GALNT14, that was highly expressed in osteosarcoma. This gene was closely associated with metastasis, progression, cuproptosis-related genes, and chemosensitivity of osteosarcoma, and showed correlation with poor overall survival and disease-free survival in osteosarcoma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681776 | PMC |
| http://dx.doi.org/10.1155/2023/1083423 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
GALNT14-mediated O-glycosylation drives lung adenocarcinoma progression by reducing endogenous reactive oxygen species generation.
Cell Signal
December 2024
Department of Clinical Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China; Department of Biochemistry, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, Hubei, China; Key Laboratory of Cancer Therapy Resistance and Clinical Translational Study, Shiyan 442000, Hubei, China. Electronic address:
Article Synopsis
- Aberrant glycosylation from altered glycosyltransferase expression is common in cancer, with GALNT14 being key in initiating O-GalNAcylation in lung adenocarcinoma (LUAD).
- Analysis showed that GALNT14 is often overexpressed in LUAD, linked to worse outcomes and increased tumor size and stage.
- GALNT14 promotes LUAD cell growth and invasion by reducing reactive oxygen species (ROS) through O-glycosylation of hnRNPUL1, highlighting its potential as a therapeutic target.
Immune-related glycosylation genes based classification predicts prognosis and therapy options of osteosarcoma.
Gene
January 2025
Zhejiang University, Hangzhou, Zhejiang 310058, China; Department of Orthopedics, Musculoskeletal Tumor Center, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China. Electronic address:
Osteosarcoma is the most common primary bone malignancy, with a very poor prognosis. Aberrant glycosylation is close involvement in osteosarcoma. Accordingly, this study aimed at investigating the role of glycosylation genes in the prognosis and therapy options of osteosarcoma.
View Article and Find Full Text PDFAn SNP Marker Predicts Colorectal Cancer Outcomes with 5-Fluorouracil-Based Adjuvant Chemotherapy Post-Resection.
Int J Mol Sci
June 2024
Department of Hepatology and Gastroenterology, Linkou Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan.
Article Synopsis
- Colorectal cancer (CRC) poses a significant global health risk, making the use of adjuvant chemotherapy post-surgery crucial for reducing recurrence and improving survival, especially in intermediate-stage patients.
- This study investigates the genetic mechanisms influencing the effectiveness of 5-fluorouracil (5-FU)-based chemotherapy using a genome-wide association study (GWAS) on 226 intermediate-stage CRC patients who received surgery followed by treatment.
- Key findings highlight the genetic variant -rs62139523, particularly the "A/G" genotype, as a promising biomarker that predicts better survival outcomes in these patients, though its efficacy varies based on certain demographic and clinical factors.
GALNT6, GALNT14, and Gal-3 in association with GDF-15 promotes drug resistance and stemness of breast cancer β-catenin axis.
Growth Factors
May 2024
Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India.
N-acetylgalactosaminyltransferases (GALNTs) are a polypeptide responsible for aberrant glycosylation in breast cancer (BC), but the mechanism is unclear. In this study, expression levels of GALNT6, GALNT14, and Gal-3 were assessed in BC, and their association with GDF-15, β-catenin, stemness (SOX2 and OCT4), and drug resistance marker (ABCC5) was evaluated. Gene expression of GALNT6, GALNT14, Gal-3, GDF-15, OCT4, SOX2, ABCC5, and β-catenin in tumor and adjacent non-tumor tissues ( = 30) was determined.
View Article and Find Full Text PDFBioinformatics analyses and experimental validation of ferroptosis-related genes in bronchopulmonary dysplasia pathogenesis.
PLoS One
June 2024
Department of Pediatrics, Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan, Hubei, China.
Objective: We aimed to study the involvement of ferroptosis in the pathogenesis of bronchopulmonary dysplasia (BPD) by conducting bioinformatics analyses and identifying and validating the associated ferroptosis-related genes to explore new directions for treating BPD.
Methods: The dataset GSE32472 on BPD was downloaded from the public genome database. Using R language, differentially expressed genes (DEGs) between the BPD and normal group were screened.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!